임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 예정· Limited Stage Small-Cell Lung Cancer제한기 소세포폐암 치료: 타를라타맙과 듀르발루맙 병합 vs. 듀르발루맙 단독
Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer
협력: 암젠
- 3상모집 예정· Autoimmune HepatitisA Trial of Inebilizumab in Participants With Autoimmune Hepatitis
리드: 암젠
- 3상모집 예정· Primary Immune ThrombocytopeniaA Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
리드: 암젠
- 3상모집 예정· Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic LeukemiaA Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
리드: 암젠
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
리드: 암젠
- 3상모집 중· Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
리드: 암젠
- 3상모집 중· Osteogenesis ImperfectaPediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
리드: 암젠
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 3상모집 중· Small-cell Lung CancerA Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
리드: 암젠 · 협력: 아스트라제네카
- 3상모집 중· Atherosclerotic Cardiovascular DiseaseEvaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
리드: 암젠
- 3상모집 중· Heart Failure With Preserved Ejection FractionMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
리드: 암젠
- 3상모집 중단 (진행 중)· Obesity DiseaseEfficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
리드: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM), Obesity, OverweightEfficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
리드: 암젠
- 3상모집 중· Sjögren's SyndromeA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
리드: 암젠
- 3상모집 중단 (진행 중)· Relapsing-remitting Multiple Sclerosis (RRMS)Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
리드: 암젠
- 3상모집 중단 (진행 중)· Metastatic Castration-resistant Prostate CancerPhase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
리드: 암젠
- 3상모집 중단 (진행 중)· Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
리드: 암젠
- 3상모집 중단 (진행 중)· Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerA Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
리드: 암젠
- 3상모집 중단 (진행 중)· Prurigo NodularisA Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
리드: 암젠
- 3상모집 중단 (진행 중)· Extensive-Stage Small-Cell Lung CancerStudy Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
리드: 암젠
- 3상모집 중단 (진행 중)· Osteogenesis ImperfectaStudy to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
리드: 암젠
- 3상모집 중단 (진행 중)· Sjögren's Syndrome (SS)A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
리드: 암젠
- 3상모집 중단 (진행 중)· Limited Stage Small Cell Lung CancerStudy Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
리드: 암젠
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
리드: 암젠
- 3상모집 중단 (진행 중)· Small Cell Lung Cancer (SCLC)Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
리드: 암젠
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
리드: 암젠
- 3상모집 중· Acute Lymphoblastic LeukemiaInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
협력: 암젠
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
리드: 암젠
- 3상모집 중단 (진행 중)· Eosinophilic EsophagitisEfficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Active Juvenile Psoriatic ArthritisApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
리드: 암젠
- 3상모집 중단 (진행 중)· Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 3상모집 중· Behçet DiseaseApremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
리드: 암젠
- 3상모집 중단 (진행 중)· IgG4 Related DiseaseA Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
리드: 암젠
- 3상모집 중단 (진행 중)· Multiple MyelomaIsa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
협력: 암젠, 사노피
- 3상모집 중· Leukemia, Acute LymphoblasticA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
협력: 암젠, 화이자
- 3상모집 중단 (진행 중)· KRAS p, G12c Mutated /Advanced Metastatic NSCLCStudy to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
리드: 암젠
- 3상모집 중단 (진행 중)· Chemotherapy-induced ThrombocytopeniaStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
리드: 암젠
- 3상모집 중· Secondary HyperparathyroidismA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
리드: 암젠
- 3상모집 중단 (진행 중)· MigraineEfficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
리드: 암젠 · 협력: 노바티스
- 3상모집 중· Secondary HyperparathyroidismA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.